Meta has suspended the use of its generative artificial intelligence (GenAI) in Brazil following a preliminary ban by the country’s data protection authority over its new privacy policy. The agency also imposed a daily fine for non-compliance. Personal data usage to train AI systems has raised privacy concerns globally, leading some companies, including Apple and Meta, to withhold AI features in regions with stricter data privacy laws.
Startup OMass Secures $310M to Advance Drug for Rare Endocrine Disorder
OMass’s molecule is vying to become an alternative to a Neurocrine Biosciences drug that is currently the only FDA-approved therapy for congenital adrenal hyperplasia. But
